Form 4: BioVie Inc. Director Robert Hariri Acquires Stock Options

Director Robert Hariri reports acquisition of stock options in BioVie Inc.

Summary

• Robert Hariri, a director of BioVie Inc., filed a Form 4 disclosing changes in beneficial ownership.
• The report details the acquisition of stock options.
• Hariri acquired 49,800 stock options with an exercise price of $3.36, vesting in four equal installments starting February 8, 2025, and expiring on November 20, 2029.
• He also acquired 21,815 stock options with an exercise price of $1.9, vesting in three equal installments starting December 20, 2024, and expiring on December 20, 2029.
• Following these transactions, Hariri directly owns 49,800 and 21,815 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's action could be interpreted as a positive signal, but it's not definitively bullish.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director may have a slight positive impact on shareholder sentiment.

Key Dates